Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Saudi anti-human cancer plants database (SACPD): A collection of plants with anti-human cancer activities.

Al-Zahrani AA.

Oncol Rev. 2018 Mar 26;12(1):349. doi: 10.4081/oncol.2018.349. eCollection 2018 Jan 30.

2.

The impact of Mir-9 regulation in normal and malignant hematopoiesis.

Khosravi A, Alizadeh S, Jalili A, Shirzad R, Saki N.

Oncol Rev. 2018 Mar 27;12(1):348. doi: 10.4081/oncol.2018.348. eCollection 2018 Jan 30.

3.

Punica granatum (Pomegranate) activity in health promotion and cancer prevention.

Bassiri-Jahromi S.

Oncol Rev. 2018 Jan 30;12(1):345. doi: 10.4081/oncol.2018.345. eCollection 2018 Jan 30.

4.

Carcinogenesis-relevant biological events in the pathophysiology of the efferocytosis phenomenon.

Sarode GS, Sarode SC, Maniyar N, Sharma NK, Patil S.

Oncol Rev. 2017 Dec 12;11(2):343. doi: 10.4081/oncol.2017.343. eCollection 2017 Jun 14. Review. No abstract available.

5.

Povidone-iodine for the management of oral mucositis during cancer therapy.

Kanagalingam J, Chopra A, Hong MH, Ibrahim W, Villalon A, Lin JC.

Oncol Rev. 2017 Sep 15;11(2):341. doi: 10.4081/oncol.2017.341. eCollection 2017 Jun 14.

6.

Centralization of Liver Cancer Surgery and Impact on Multidisciplinary Teams Working on Stage IV Colorectal Cancer.

Weledji EP.

Oncol Rev. 2017 Jul 31;11(2):331. doi: 10.4081/oncol.2017.331. eCollection 2017 Jun 14. Review.

7.

Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: The Moffitt Cancer Center Experience.

Fradley MG, Brown AC, Shields B, Viganego F, Damrongwatanasuk R, Patel AA, Hartlage G, Roper N, Jaunese J, Roy L, Ismail-Khan R.

Oncol Rev. 2017 Jul 18;11(2):340. doi: 10.4081/oncol.2017.340. eCollection 2017 Jun 14. Review.

8.

Current Management Options in Metastatic Renal Cell Cancer.

Gangadaran SGD.

Oncol Rev. 2017 Jun 14;11(2):339. doi: 10.4081/oncol.2017.339. eCollection 2017 Jun 14. Review.

9.

Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology.

Naoum GE, Buchsbaum DJ, Tawadros F, Farooqi A, Arafat WO.

Oncol Rev. 2017 Apr 28;11(1):332. doi: 10.4081/oncol.2017.332. eCollection 2017 Mar 3. Review.

10.

Novel Strategies to Improve the Endocrine Therapy of Breast Cancer.

Castrellon AB.

Oncol Rev. 2017 May 16;11(1):323. doi: 10.4081/oncol.2017.323. eCollection 2017 Mar 3. Review.

11.

Bone Metastases: An Overview.

Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, Goncalves F.

Oncol Rev. 2017 May 9;11(1):321. doi: 10.4081/oncol.2017.321. eCollection 2017 Mar 3. Review.

12.

Chemotherapy Resistance Mechanisms in Advanced Skin Cancer.

Kalal BS, Upadhya D, Pai VR.

Oncol Rev. 2017 Mar 24;11(1):326. doi: 10.4081/oncol.2017.326. eCollection 2017 Mar 3. Review.

13.

Paradoxical Role of High Mobility Group Box 1 in Glioma: A Suppressor or a Promoter?

Seidu RA, Wu M, Su Z, Xu H.

Oncol Rev. 2017 Mar 3;11(1):325. doi: 10.4081/oncol.2017.325. eCollection 2017 Mar 3. Review.

14.

The Role of Carboplatin in the Neoadjuvant Chemotherapy Treatment of Triple Negative Breast Cancer.

Castrellon AB, Pidhorecky I, Valero V, Raez LE.

Oncol Rev. 2017 Mar 17;11(1):324. doi: 10.4081/oncol.2017.324. eCollection 2017 Mar 3. Review.

15.

An Updated Review of Cribriform Carcinomas with Emphasis on Histopathological Diagnosis and Prognostic Significance.

Branca G, Ieni A, Barresi V, Tuccari G, Caruso RA.

Oncol Rev. 2017 Mar 10;11(1):317. doi: 10.4081/oncol.2017.317. eCollection 2017 Mar 3. Review.

16.

Urinary Bladder Cancer: Biomarkers and Target Therapy, New Era for More Attention.

Mohammed AA, El-Tanni H, El-Khatib HM, Mirza AA, Mirza AA, Alturaifi TH.

Oncol Rev. 2016 Dec 14;10(2):320. doi: 10.4081/oncol.2016.320. eCollection 2016 Oct 10. Review.

17.

Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights.

Shahrabi S, Khosravi A, Shahjahani M, Rahim F, Saki N.

Oncol Rev. 2016 Dec 14;10(2):311. doi: 10.4081/oncol.2016.311. eCollection 2016 Oct 10. Review.

18.

Breast Ductal Carcinoma In Situ: A Literature Review of Adjuvant Hormonal Therapy.

Kinsey-Trotman S, Shi Z, Fosh B.

Oncol Rev. 2016 Dec 7;10(2):304. doi: 10.4081/oncol.2016.304. eCollection 2016 Oct 10. Review.

19.

A Novel Role of Lamins from Genetic Disease to Cancer Biomarkers.

Sakthivel KM, Sehgal P.

Oncol Rev. 2016 Nov 14;10(2):309. eCollection 2016 Oct 10. Review.

20.

Bone Marrow Blood Vessels: Normal and Neoplastic Niche.

Shahrabi S, Rezaeeyan H, Ahmadzadeh A, Shahjahani M, Saki N.

Oncol Rev. 2016 Nov 24;10(2):306. eCollection 2016 Oct 10. Review.

Supplemental Content

Loading ...
Support Center